By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Gentium S.p.A. 

Como      Italy
Phone: N/A Fax:



Company News
Gentium S.p.A. Announces Decision To Voluntarily Delist American Depositary Shares From The NASDAQ Global Market 3/6/2014 9:30:19 AM
Jazz Pharmaceuticals plc (JAZZ) Completes Tender Offer For Gentium S.p.A. Shares 2/21/2014 9:11:05 AM
Jazz Pharmaceuticals plc (JAZZ) Announces Minimum Tender Condition Exceeded During Initial Offering Period For Gentium S.p.A. Shares 1/23/2014 11:07:56 AM
Gentium S.p.A. Shareholders Sue Over $1 Billion Jazz Pharmaceuticals plc (JAZZ) Deal 1/17/2014 7:21:23 AM
Jazz Pharmaceuticals plc (JAZZ) Pays A Whopping $1 Billion For Rare Disease Drug Developer Gentium S.p.A. 12/20/2013 6:29:02 AM
Interim Results From Gentium S.p.A.'s Treatment IND For Defibrotide And Additional Data On Defibrotide In The Prevention Of Acute Graft Versus Host Disease (Agvhd) Presented At The American Society of Hematology Annual Meeting 12/11/2013 7:53:03 AM
Gentium S.p.A. Release: Data From Non HSCT VOD Patients Treated With Defibrotide And A Treatment IND Update To Be Presented At The American Society of Hematology 2013 Annual Meeting 11/26/2013 9:52:09 AM
Gentium S.p.A. Receives European Medicines Agency Orphan Drug Designation For Defibrotide For The Prevention Of GvHD 11/19/2013 9:11:12 AM
Gentium S.p.A. Announces Successful Completion Of Defibrotide Phase 1 Study In Japan 11/12/2013 12:55:15 PM
Gentium S.p.A. Reports Third Quarter 2013 Financial Results 10/31/2013 10:04:37 AM